| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/09/2005 | CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 03/09/2005 | CN1590373A Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 03/09/2005 | CN1589889A Extract of plant dendrobii caulis and preparing process and use thereof |
| 03/09/2005 | CN1589887A Medicial composition for treating lithiasis and its preparation method |
| 03/09/2005 | CN1589830A Miao nationality medicine for treating enuresis and its compounding method |
| 03/09/2005 | CN1589778A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1589777A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1589776A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 03/09/2005 | CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 03/09/2005 | CN1191844C Smelling treated Chinese medicine |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864280 Hypotensive agents; cardiovascular disorders |
| 03/08/2005 | US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders |
| 03/08/2005 | US6864266 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6864262 Bladder disorders; incontinence; side effect reduction |
| 03/08/2005 | US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer |
| 03/08/2005 | US6864247 Therapeutic agents for glomerulosclerosis |
| 03/08/2005 | US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 03/08/2005 | US6862890 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 03/03/2005 | WO2005019245A1 Heptadepsin |
| 03/03/2005 | WO2005019188A1 Fused pyrimidine derivative and use thereof |
| 03/03/2005 | WO2005018672A1 Drug containing chymase inhibitor as the active ingredient |
| 03/03/2005 | WO2005018651A1 Pharmaceutical formulation comprising lanthanum compounds |
| 03/03/2005 | WO2005018649A1 Agent for inhibiting the formation of final saccharification product |
| 03/03/2005 | WO2005018643A1 Metabolites of 1-{3-4`4-(2-methoxyphenyl) piperazin-1-yl!-propyl}-piperidine-2, 6-dione for use in the treatment of benign prostatic hyperplasia |
| 03/03/2005 | WO2005018627A1 Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| 03/03/2005 | WO2005018528A2 Method for the treatment prophylaxis and differential diagnosis of prostatitis |
| 03/03/2005 | WO2005018341A1 Food for testing life style-related diseases |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | US20050050589 Soya cell strains with high isoflavone content |
| 03/03/2005 | US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same |
| 03/03/2005 | US20050049303 Adamantane derivatives |
| 03/03/2005 | US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 03/03/2005 | US20050049290 Benzimidazole derivatives and their use as gnrh antagonists |
| 03/03/2005 | US20050049264 Suppressing growth of abnormal cells; gastric, brain, colon, pancreatic, lung, renal, ovarian and prostatic cancer |
| 03/03/2005 | US20050049259 Viricides; for the prophylaxis and treatment of herpes viral infections |
| 03/03/2005 | US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 03/03/2005 | US20050049251 Inhibitors of p38 |
| 03/03/2005 | US20050049241 Vanilloid receptor antagonists; acute or chronic pain, itching; inflammation; gastrointestinal and urinary tract disorders; tracheobronchial and diaphragmatic dysfunction |
| 03/03/2005 | US20050049217 Stimulating the proliferation of kidney tubule epithelial cells in vivo using Zvegf4, a mitogenic multidomain protein with homology to the PDGF/VEGF family of growth factors; platelet-derived growth factor (PDGF); vascular endothelial growth factors (VEGF); renal failure |
| 03/03/2005 | US20050049200 Administering a luteinizing hormone-releasing hormone antagonist (LH-RH) in an amount to suppress endogenous LH while maintaining follicle stimulating hormone (FSH) secretion at a natural level and estrogen development is not affected up to ovulation induction |
| 03/03/2005 | US20050049190 Cation conducting gabaa receptors and their use |
| 03/03/2005 | US20050048602 Kidney repairing factor |
| 03/03/2005 | US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 03/03/2005 | US20050048137 Extract of plant dendrobii caulis and preparing process thereof |
| 03/03/2005 | US20050048107 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml |
| 03/03/2005 | US20050048106 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml |
| 03/03/2005 | US20050048055 Use of CD40 engagement to alter T cell receptor usage |
| 03/03/2005 | US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 03/03/2005 | US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine |
| 03/03/2005 | US20050048026 Remedies for ischemic diseases |
| 03/03/2005 | US20050047958 Methods for sterilizing preparations of digestive enzymes |
| 03/03/2005 | CA2536764A1 .alpha.-aminoamide derivatives useful as anti-inflammatory agents |
| 03/03/2005 | CA2536435A1 Drug containing chymase inhibitor as the active ingredient |
| 03/03/2005 | CA2536313A1 Fused pyrimidine derivative and use thereof |
| 03/02/2005 | EP1510218A1 Extract of plant dendrobii caulis and preparing process thereof |
| 03/02/2005 | EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 03/02/2005 | EP1509541A2 Novel recombinant anticoagulant proteins |
| 03/02/2005 | EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| 03/02/2005 | EP1509524A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/02/2005 | EP1509521A2 1h-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 03/02/2005 | EP1509506A1 Pyridazine derivatives |
| 03/02/2005 | EP1509499A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases |
| 03/02/2005 | EP1509498A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same |
| 03/02/2005 | EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/02/2005 | EP1509249A2 Inclusion complexes of rosiglitazone |
| 03/02/2005 | EP1509241A1 Novel uses of cephaibols |
| 03/02/2005 | EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 03/02/2005 | EP1509215A1 Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1509086A2 Htlv-i tax induced killing of p53 null cancer cells |
| 03/02/2005 | EP1244649B1 Cyclic amp-specific phosphodiesterase inhibitors |
| 03/02/2005 | EP1014976B1 Novel substituted imidazole compounds |
| 03/02/2005 | EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 03/02/2005 | CN1589279A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1589140A Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 03/02/2005 | CN1589139A Modified release tamsulosin tablets |
| 03/02/2005 | CN1587269A Medicinal composition containing angiotensin II receptor antagonist and vitamin B |
| 03/02/2005 | CN1586603A Medicinal composition for treating urinary lithiasis and its preparing method |
| 03/02/2005 | CN1586601A Coupling agent for external stone crushing and its preparing method |
| 03/02/2005 | CN1586600A Tibet medicine lamivphlomis root injection preparation and its preparing method |
| 03/02/2005 | CN1586586A Chinese medicine preparation for treating urinary system infection and its preparing method |
| 03/02/2005 | CN1586565A Recovery pill for prostate gland |
| 03/02/2005 | CN1586535A Liuweidihuang effervescent tablet and its preparing method |
| 03/02/2005 | CN1586533A Composition for strengthening body resistance and restoring and function, strengthening spleen and kidney, relieving metal stress and promoting blood circulation to remove blood stasis |
| 03/02/2005 | CN1586531A Chinese medicine particle for treating chronic hyperplasia of prostate |
| 03/02/2005 | CN1586524A External medicine for treating lithiasis |
| 03/02/2005 | CN1586523A Chinese patented medicine for treating complication caused by non-gonorrhea and gonorrhea |
| 03/02/2005 | CN1586518A Method for preparing injection for treating urinary inflection and enteritis of livestock |
| 03/02/2005 | CN1586502A Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 03/02/2005 | CN1586486A Cefpodoxime proxetil soft capsule preparation and its preparing method |